145 studies found for:    Non-Alcoholic Steatohepatitis
Show Display Options
RSS Create an RSS feed from your search for:
Non-Alcoholic Steatohepatitis
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis
Interventions: Drug: Atorvastatin;   Drug: L-Carnitine;   Drug: Placebo
2 Completed The Effect of Protandim on Non-alcoholic Steatohepatitis
Condition: Non-Alcoholic Steatohepatitis
Interventions: Dietary Supplement: Protandim;   Dietary Supplement: Placebo
3 Recruiting Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
4 Active, not recruiting Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis
Condition: Non-cirrhotic Non-alcoholic Steatohepatitis
Interventions: Other: Placebo;   Drug: Silymarin
5 Enrolling by invitation Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis
Condition: •Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: Ezetimibe;   Behavioral: Lifestyle
6 Completed The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis
Conditions: Non-alcoholic Steatohepatitis;   Increased Iron Storage / Disturbed Distribution
Intervention: Drug: Exjade
7 Active, not recruiting Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GFT505 80mg;   Drug: GFT505 120mg;   Drug: Placebo
8 Enrolling by invitation Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GR-MD-02;   Drug: Placebo
9 Recruiting Simtuzumab (GS-6624) in the Treatment of Liver Fibrosis in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab 75 mg;   Biological: Simtuzumab 125 mg;   Biological: Placebo
10 Completed Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Intervention: Drug: TRO19622
11 Recruiting Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS)
Conditions: Nonalcoholic Steatohepatitis;   Hypogonadism
Intervention: Drug: testosterone undecanoate
12 Unknown  Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children
Condition: Non-Alcoholic Steatohepatitis
Intervention:
13 Completed Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Steatohepatitis;   Fatty Liver
Interventions: Drug: Omega 3 Fish Oil supplements;   Drug: Placebo
14 Completed Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
Conditions: Fatty Liver;   Nonalcoholic Steatohepatitis
Intervention: Drug: Pioglitazone
15 Completed A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: ASP9831;   Drug: Placebo
16 Terminated
Has Results
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis (NASH);   Hepatic Steatosis
Interventions: Drug: Omega-3-acid ethyl esters (Lovaza);   Drug: Placebo
17 Active, not recruiting Polypill and Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: Polypill
18 Completed Effects of Alanine in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: L-alanine
19 Completed Betaine in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Cystadane;   Drug: Identical Placebo
20 Completed
Has Results
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: pentoxifylline (PTX);   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years